Effectiveness of upadacitinib in Japanese patients with prurigo‐type atopic dermatitis: Four cases report

Keiji Kosaka; Akihiko Uchiyama; Mai Ishikawa; Sei‐ichiro Motegi

doi:10.1002/cia2.12333

Journal of Cutaneous Immunology and Allergy (Dec 2023)

Effectiveness of upadacitinib in Japanese patients with prurigo‐type atopic dermatitis: Four cases report

Keiji Kosaka,
Akihiko Uchiyama,
Mai Ishikawa,
Sei‐ichiro Motegi

Affiliations

Keiji Kosaka: Department of Dermatology Gunma University Graduate School of Medicine Maebashi Gunma Japan
Akihiko Uchiyama: Department of Dermatology Gunma University Graduate School of Medicine Maebashi Gunma Japan
Mai Ishikawa: Department of Dermatology Gunma University Graduate School of Medicine Maebashi Gunma Japan
Sei‐ichiro Motegi: Department of Dermatology Gunma University Graduate School of Medicine Maebashi Gunma Japan

DOI: https://doi.org/10.1002/cia2.12333
Journal volume & issue: Vol. 6, no. 6
pp. 262 – 263

Abstract

Read online

We present four Japanese patients with prurigo‐type AD who received upadacitinib. Rapid improvement of skin lesions and itchiness was seen in all patients. Janus kinase inhibitor is effective for prurigo‐type AD by strongly suppressing itching.

Published in Journal of Cutaneous Immunology and Allergy

ISSN: 2574-4593 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Dermatology; Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: https://www.frontierspartnerships.org/journals/journal-of-cutaneous-immunology-and-allergy

About the journal